1307 related articles for article (PubMed ID: 34225607)
1. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
2. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
3. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.
Jamshidnia M; Sewell RDE; Rafieian-Kopaei M
Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets.
Yapasert R; Khaw-On P; Banjerdpongchai R
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946543
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Idrees M; Khan S; Memon NH; Zhang Z
Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
[TBL] [Abstract][Full Text] [Related]
6. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies.
Boozari M; Hosseinzadeh H
Phytother Res; 2021 Feb; 35(2):864-876. PubMed ID: 32985017
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm.
Choe J; Har Yong P; Xiang Ng Z
Chem Biodivers; 2022 Nov; 19(11):e202200655. PubMed ID: 36125969
[TBL] [Abstract][Full Text] [Related]
8. Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis.
Ebenezer O; Bodede O; Awolade P; Jordaan MA; Ogunsakin RE; Shapi M
Acta Pharm; 2022 Jun; 72(2):199-224. PubMed ID: 36651508
[TBL] [Abstract][Full Text] [Related]
9. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
Murugesan S; Kottekad S; Crasta I; Sreevathsan S; Usharani D; Perumal MK; Mudliar SN
Comput Biol Med; 2021 Sep; 136():104683. PubMed ID: 34329860
[TBL] [Abstract][Full Text] [Related]
10. Herbal Medicines to Fight Against COVID-19: New Battle with an Old Weapon.
Harwansh RK; Bahadur S
Curr Pharm Biotechnol; 2022; 23(2):235-260. PubMed ID: 33749558
[TBL] [Abstract][Full Text] [Related]
11. The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion.
Chen TH; Tsai MJ; Chang CS; Xu L; Fu YS; Weng CF
J Infect Public Health; 2023 Jan; 16(1):42-54. PubMed ID: 36470006
[TBL] [Abstract][Full Text] [Related]
12. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
13. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL
Mouffouk C; Mouffouk S; Mouffouk S; Hambaba L; Haba H
Eur J Pharmacol; 2021 Jan; 891():173759. PubMed ID: 33249077
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
16. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
17. Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs.
Merarchi M; Dudha N; Das BC; Garg M
Phytother Res; 2021 Oct; 35(10):5384-5396. PubMed ID: 34132421
[TBL] [Abstract][Full Text] [Related]
18. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Activity of Medicinal Plants against Human Coronavirus: a systematic scoping review of and experimentations.
Namiranian P; Sadatpour O; Azimzadeh Jamalkandi S; Hossein Ayati M; Karimi M
J Tradit Chin Med; 2022 Jun; 42(3):332-343. PubMed ID: 35610002
[TBL] [Abstract][Full Text] [Related]
20. Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery.
Amin SA; Ghosh K; Singh S; Qureshi IA; Jha T; Gayen S
Mol Divers; 2022 Feb; 26(1):215-228. PubMed ID: 33675510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
